1. Home
  2. DCI vs BIO Comparison

DCI vs BIO Comparison

Compare DCI & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Donaldson Company Inc.

DCI

Donaldson Company Inc.

HOLD

Current Price

$93.00

Market Cap

10.6B

Sector

Industrials

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$363.65

Market Cap

8.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCI
BIO
Founded
1915
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Pollution Control Equipment
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.6B
8.0B
IPO Year
2005
1994

Fundamental Metrics

Financial Performance
Metric
DCI
BIO
Price
$93.00
$363.65
Analyst Decision
Buy
Buy
Analyst Count
5
4
Target Price
$99.00
$339.75
AVG Volume (30 Days)
557.6K
277.5K
Earning Date
06-02-2026
04-30-2026
Dividend Yield
1.38%
N/A
EPS Growth
N/A
142.61
EPS
2.75
N/A
Revenue
$2,844,900,000.00
$2,583,200,000.00
Revenue This Year
$4.58
$2.74
Revenue Next Year
$5.18
$3.20
P/E Ratio
$34.17
N/A
Revenue Growth
4.05
0.65
52 Week Low
$73.63
$236.73
52 Week High
$112.84
$365.00

Technical Indicators

Market Signals
Indicator
DCI
BIO
Relative Strength Index (RSI) 50.48 72.22
Support Level $85.48 $289.16
Resistance Level $94.26 N/A
Average True Range (ATR) 1.98 11.72
MACD -0.56 0.41
Stochastic Oscillator 29.74 92.31

Price Performance

Historical Comparison
DCI
BIO

About DCI Donaldson Company Inc.

Donaldson is a leading manufacturer of filtration systems and replacement parts, including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors. The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.7 billion in revenue in its fiscal 2025.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: